Products

Purified Malathion Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions

    • Product Name: Purified Malathion Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions
    • Factroy Site: Yudu County, Ganzhou, Jiangxi, China
    • Price Inquiry: sales10@sinochem-nanjing.com
    • Manufacturer: Ascent Petrochem Holdings Co., Limited
    • CONTACT NOW
    VTB
    Specifications
    HS Code 873949
    Product Name Purified Malathion Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions
    Chemical Name Diethyl 2-[(dimethoxyphosphorothioyl)sulfanyl]butanedioate
    Cas Registry Number 121-75-5
    Molecular Formula C10H19O6PS2
    Molecular Weight 330.36 g/mol
    Appearance Colorless to pale yellow liquid
    Odor Characteristic sulfurous or garlic-like odor
    Purity ≥95% (veterinary grade)
    Grade Veterinary Grade API
    Physical State Liquid at room temperature
    Solubility In Water Slightly soluble, approximately 145 mg/L at 20°C
    Solubility In Organic Solvents Miscible with alcohols, ketones, esters, and aromatic hydrocarbons
    Melting Point 2.9°C
    Boiling Point 156-157°C at 0.7 mmHg
    Density 1.23 g/cm³ at 20°C
    Vapor Pressure 5.3 mPa at 20°C
    Storage Conditions Store in a cool, dry, well-ventilated area away from heat, oxidizers, and alkalis
    Dosage Forms Tablets, injections, capsules, powders, granules, premix, solutions
    Primary Veterinary Use Ectoparasiticide and acaricide for control of fleas, ticks, lice, and mites on animals
    Mechanism Of Action Inhibits acetylcholinesterase, causing accumulation of acetylcholine and paralysis in parasites
    Target Species Cattle, sheep, goats, horses, dogs, cats, and other animals as directed by a veterinarian
    Withdrawal Period Follow species-specific and regulatory withdrawal times; typically meat and milk withdrawal required
    Hazard Class Organophosphate insecticide; toxic if swallowed, inhaled, or absorbed through skin
    Regulatory Status Veterinary API subject to national and international pesticide and drug regulations

    As an accredited Purified Malathion Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing Packaged in 25 kg polyethylene-lined fiber drums with double seals for Purified Malathion Veterinary Grade API, ensuring protection during storage and transport.
    Container Loading (20′ FCL) 20′ FCL container loading: Purified Malathion Veterinary Grade API for tablets, injections, capsules, powders, granules, premix, solutions, securely palletized/drummed and compliant.
    Shipping Purified Malathion Veterinary Grade API for tablets, injections, capsules, powders, granules, premix, or solutions ships in sealed, moisture-resistant, labeled containers. Classified toxic (Class 6.1, UN 2783, PG III) when applicable. Follow ADR/IMDG/IATA, use approved hazardous-goods packaging and documentation. Store cool, dry, away from food, feed, oxidizers, and sunlight.
    Storage Store in tightly sealed, labeled containers in a cool, dry, well-ventilated, secure area. Protect from light, moisture, heat, and ignition sources. Keep separate from food, feed, and incompatible materials such as alkalis and oxidizers. Maintain temperature as labeled, typically 15–25°C (59–77°F). Use original packaging, keep closed when not in use, and follow cGMP, pharmacopeial, and local regulatory requirements.
    Shelf Life Purified Malathion Veterinary Grade API shelf life: typically 24–36 months when stored sealed, cool, dry, protected from light, per manufacturer.
    Application of Purified Malathion Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions

    How Does Malathion API Behave in Recirculating Sheep Plunge Dip Systems?

    Sheep plunge dipping constitutes an immersion ectoparasiticide delivery system in which the primary clinical targets include Psoroptes ovis (sheep scab mite), Bovicola ovis (sheep biting louse), Linognathus ovillus (sheep sucking louse), and Melophagus ovinus (sheep ked). Malathion exerts contact toxicity through inhibition of acetylcholinesterase at the pest neural synapse; the organophosphate moiety requires direct contact with the parasite cuticle because systemic absorption through ovine skin is limited and the compound is not approved for oral or parenteral administration in ruminants. In recirculating plunge dip systems, the active concentration in the wash is maintained between 500 mg/L and 1000 mg/L (0.05–0.10% w/v), achieved by diluting a 50–60% w/w emulsifiable concentrate (EC) intermediate at point of use. The dilution factor is adjusted according to pest pressure, fleece length, dip bath volume, and water hardness. The dip wash is a chemically dynamic environment: wool adsorbs a significant fraction of the active ingredient during each animal passage—an operational phenomenon termed stripping—which progressively depletes wash concentration by 15–40% after approximately 100 sheep have passed through a 10,000-L bath, a commonly reported figure in published dipping management literature. Replenishment protocols therefore specify continuous or batch addition of fresh EC at a rate calculated from animal throughput, typically 100–200 mL of 50% EC per additional sheep beyond the initial 100, although the exact rate must be validated against periodic wash analysis using CIPAC-compliant gas chromatography with flame ionization detection. Malathion hydrolyzes via base-catalyzed ester cleavage, and the degradation rate accelerates markedly above pH 7.0. Dip wash pH is maintained at 5.0–6.5 through buffering agents, and operators monitor pH at 30-minute intervals during dipping operations; elevated pH above 7.5 reduces hydrolytic half-life to less than 24 hours under ambient conditions, necessitating increased replenishment or complete bath replacement. Temperature modifies stability as well: dip wash maintained below 20°C limits hydrolysis, while temperatures above 25°C increase both hydrolysis rate and vapor-phase losses from the bath surface. In cold conditions below 5°C, the reconstituted EC emulsion exhibits elevated viscosity and phase separation risk, requiring pre-warming of the concentrate to 15–25°C before addition to the dip bath. Water hardness above 300 mg/L CaCO₃ destabilizes the anionic emulsifier fraction and can produce visible creaming within 4 hours; formulators compensate by increasing the nonionic ethoxylate emulsifier fraction or by incorporating a calcium-sequestering agent such as tetrasodium EDTA at 0.1–0.2% w/w of the finished concentrate. The compliance framework for sheep dip EC formulations in multiple jurisdictions requires the finished veterinary medicinal product to satisfy VICH GL11 (stability testing) with a demonstrated shelf life of 24 months at 25°C and 60% relative humidity, VICH GL18 (residual solvent limits for aromatic hydrocarbon excipients), and VICH GL1 (validated HPLC assay for active content; typical specification 50–59% w/w with a tolerance of ±2% of label claim). The purified API itself must meet a veterinary-grade impurity profile in which isomalathion content is limited to prevent delayed mammalian neurotoxicity potentiation and malaoxon is controlled as an oxidation product exhibiting significantly higher acetylcholinesterase inhibition potency than the parent thion. In the United States, malathion tolerances in sheep tissues are codified at 21 CFR 556.370; the EPA tolerance is listed at 40 CFR 180.111. Dip bath disposal is regulated under national groundwater protection statutes and requires a licensed waste contractor unless an on-farm disposal permit has been granted; residual dip fluid must not be discharged into surface water, and solid sludge from dip sumps is classified as hazardous waste in several jurisdictions.

    The downstream formulation of malathion sheep dip EC concentrates proceeds in jacketed stainless steel mixing vessels with working volumes of 500–5000 L. The manufacturing sequence is as follows: aromatic hydrocarbon solvent (xylene-range alkylbenzene blend or high-flash aromatic fluid, flash point 40–60°C as measured by ASTM D93 Pensky-Martens closed cup method) is charged to the vessel at 60–70% of final batch weight; purified malathion API is added via vacuum transfer (the technical API is a low-viscosity amber liquid at 20°C with density approximately 1.23 g/cm³ and freezing point near 2.9°C) and dissolved under low-shear agitation at 30–40°C for 30–60 minutes; an emulsifier blend consisting of calcium dodecylbenzenesulfonate (anionic) and a nonionic alcohol ethoxylate (HLB 10–13) is then added at 3–6% w/w of the final formulation; homogenization at 1500–3000 rpm for 15–30 minutes completes the concentrate. The finished EC is filtered through 50–100 µm cartridge filters and packaged into HDPE or fluorinated HDPE containers of 1 L, 5 L, or 20 L capacity. Quality control on the EC involves CIPAC MT 36 emulsion stability testing: a 5-mL aliquot of EC is added to standard hard water (342 mg/L CaCO₃ equivalent) at 30°C and left standing for 24 hours; cream separation volume must not exceed 2 mL and oil separation must be zero. Cold storage at 5°C for 7 days must show no crystal growth. Accelerated stability at 54°C for 14 days must retain at least 95% of labeled active. The API grade used for these formulations must have a minimum purity of 95% w/w, water content below 1.0%, and acidity (as H₂SO₄) below 0.5%. End product types registered for sheep dip use include: 50% w/v EC in 1-L bottles for small-flock use; 55% w/v EC in 20-L drums for commercial operators; pre-diluted dip wash in 200-L drums for direct application; and water-soluble sachet formulations at 40% w/w active where solvent-reduced delivery is required under specific regulatory constraints.

    Downstream Use SectorPrimary Registration FrameworkFood/Feed Tolerance StandardAPI Quality AnchorOccupational Compliance Standard
    Sheep plunge dip ECVeterinary medicinal product registration or pesticide regulator21 CFR 556.370; 40 CFR 180.111VICH GL1; VICH GL11; VICH GL18; isomalathion capped; purity ≥95%29 CFR 1910.1000 Table Z-1; OSHA PEL 15 mg/m³ total dust
    Poultry red mite dustEPA FIFRA Section 3 or equivalent national biocide registration21 CFR 556.370; EU Regulation (EC) No 396/2005CIPAC GC-FID assay; label claim tolerance ±10% relative29 CFR 1910.1200; dust containment per local exhaust ventilation
    Cattle backrubber / oiler solutionEPA FIFRA Section 3 or veterinary product registration21 CFR 556.370; 40 CFR 180.111VICH GL11; ASTM D445 viscosity; ASTM D93 flash point29 CFR 1910.1000 Table Z-1
    Livestock / poultry housing sprayEPA FIFRA Section 3; EU BPR (EU) No 528/201240 CFR 180.111VICH GL18; CIPAC MT 36 emulsion stability29 CFR 1910.1200; Worker Protection Standard
    Swine lice / mange sprayVeterinary medicinal product registration21 CFR 556.370; 40 CFR 180.111VICH GL1; VICH GL11; purity ≥95%29 CFR 1910.1000 Table Z-1; dermal PPE
    Companion animal topical solutionFragmented: FDA/CVM, EPA, or pharmacy compounding under veterinary prescriptionNo MRL for topical route; oral and parenteral routes unregisteredIsomalathion ≤0.2% w/w; malaoxon ≤0.1% w/w; bioburden ≤100 CFU/g29 CFR 1910.1000 Table Z-1; 29 CFR 1910.1200

    Dermanyssus gallinae, the poultry red mite, is a hematophagous ectoparasite that spends the majority of its lifecycle off-host within structural harborage in caged layer and breeder facilities. Nocturnal feeding behavior—combined with off-host egg deposition in cracks, nest boxes, slat junctions, and manure belt assemblies—dictates that an effective malathion intervention must deliver residual activity against both motile mites and emerging nymphs. Dusting powder formulations containing 4.0–5.0% w/w malathion on a mineral carrier are applied directly to birds and to harborage surfaces. The critical performance parameter for this dosage form is particle size distribution: a D50 of 20–50 µm with a D90 below 100 µm ensures adhesion to feather shafts and penetration into the down layer where mites initiate feeding, whereas larger particles (D50 above 100 µm) cause poor avian retention and excessive dust fall-off onto manure surfaces. Carrier selection is not arbitrary; talc (hydrous magnesium silicate) provides a high specific surface area (BET 6–12 m²/g) and good flow properties; kaolin offers lower cost but requires additional anti-caking agent; diatomaceous earth contributes abrasive action against mite cuticle but can elevate airborne dust generation during application. Fumed silica is added at 0.5–1.0% w/w as an anti-caking flow aid, and calcium carbonate is occasionally incorporated at 10–20% w/w as a density modifier to reduce airborne dust drift. The manufacturing process for malathion poultry dust begins with carrier pre-drying in a rotary vacuum dryer or a fluidized bed dryer at 80–110°C to reduce moisture content below 0.5% w/w. Dry carriers are then milled in a hammer mill or a pin mill with internal classifier to achieve the target D50 range; screening through 60–80 mesh (180–250 µm) removes oversize agglomerates. The purified malathion API, a free-flowing liquid at ambient temperature, is metered into the pre-blended carrier system during ribbon blending at 20–60 rpm. To prevent localized API pooling, the liquid active is sprayed through a nozzle assembly onto the tumbling powder bed at a feed rate not exceeding 2 L/min per tonne of carrier in a 2–5 m³ ribbon blender. Post-blend maturation for 30–60 minutes allows complete liquid absorption into the carrier pore structure. Finished product is discharged through a rotary valve into packaging. Compliance for this dust type falls under EPA FIFRA Section 3 registration where applicable in the United States, or equivalent national biocidal product legislation; egg withdrawal intervals of 7 days are specified in multiple registration dossiers, during which eggs from treated flocks must not enter the food chain. Residue tolerances are controlled at 21 CFR 556.370 for poultry tissues and at EU Regulation (EC) No 396/2005 for eggs and poultry meat in European markets. The API content in the finished dust must meet a label-claim tolerance of ±10% relative (for a 5% dust, acceptable range 4.5–5.5% w/w) as verified by CIPAC-compliant GC-FID analytical methods. Terminal product types include: 4% malathion dust in 0.5-kg shaker cans for direct-bird dusting; 5% dust in 10-kg bulk buckets for mechanical dusters; nest box treatment pouches; and ready-to-use pressurized dust applicators for crack and crevice treatment.

    When Malathion Is Formulated for Pastured Cattle Backrubber and Forced-Use Oiler Applications

    Pastured beef cattle are exposed to Haematobia irritans (horn fly) and Musca autumnalis (face fly) populations throughout the grazing season. Self-application devices—backrubbers and forced-use oilers—deliver a lipid-phase malathion film to the hide and hair coat, where the active ingredient residues provide continuous contact toxicity during the 10–14 day interval between device refills. The formulation format for this application differs fundamentally from the sheep dip EC: the cattle backrubber solution is not an emulsion but a true solution of malathion in a hydrocarbon or vegetable oil carrier at 0.5–2.0% w/w active. A typical concentrate for direct backrubber use contains 1.0% w/w malathion in mineral oil with a viscosity of 10–30 cSt at 40°C as determined by ASTM D445; concentrated formulations at 5.7% w/w for dilution with additional oil at the point of use are also registered in some jurisdictions. Diesel fuel was historically used as a carrier but has been withdrawn from many labels due to dermal irritation, flammability, and regulatory pressure; modern formulations use light mineral oil (white oil) or refined vegetable oil (soybean or canola) with viscosity modifiers. The function of the formulation is delimited by the transfer mechanism: backrubber fabric (burlap, canvas, or synthetic wicking material) must retain sufficient oil to wet the hair coat during a 5–10 second animal contact, without continuous dripping loss. Viscosity adjustment is critical—an oil phase below 5 cSt at 40°C causes rapid depletion from the device, while an oil phase above 50 cSt at 40°C prevents uniform distribution across the fabric. The API's lipophilicity (log Kow 2.36–2.75) ensures acceptable solubility in mineral oil without co-solvents; at ambient temperatures below 0°C, the mineral oil solution remains flowable while pure malathion (freezing point 2.9°C) does not precipitate at 1% loading due to freezing point depression in the oil mixture. UV degradation of malathion in thin films is a documented limitation: photolysis half-life on inert surfaces under full sunlight is less than 48 hours, which is why application to cattle hide (where the malathion partitions into sebaceous lipids) provides longer residual activity than application to non-animal surfaces. The manufacturing process uses a low-shear mixing vessel with recirculation pump (50–100 L/min) blending mineral oil and malathion API at 25–30°C for 30–60 minutes. Addition of butylated hydroxytoluene at 0.05–0.1 g/kg or epoxidized soybean oil at 0.5–1.0% w/w limits acid-catalyzed degradation; mineral oil carriers preclude aqueous pH adjustment because of their non-aqueous character. Filtration through 40–100 µm bag filters removes particulate contamination introduced during packaging. Quality control includes viscosity measurement per ASTM D445, flash point testing per ASTM D93 (Pensky-Martens closed cup; typical value above 100°C for mineral oil formulations), and GC-FID assay for malathion content. Compliance anchors: 21 CFR 556.370 for beef meat and fat tolerances; 40 CFR 180.111 for EPA food and feed tolerances; 29 CFR 1910.1000 Table Z-1 (OSHA PEL for malathion total dust 15 mg/m³, applicable to any dust generated during handling of the technical liquid); and VICH GL11 for stability where registration follows the pharmaceutical pathway. Withdrawal intervals for backrubber products vary from 1 to 7 days across jurisdictions and are specified on the registered label. Terminal product types: 1.0% ready-to-use backrubber oil in 5-L jugs; 5.7% backrubber concentrate in 1-L bottles for dilution; 0.5% pour-on formulation in applicator bottles for direct pour-on use; and 1.0% forced-use oiler refill solution in 20-L drums.

    Confined livestock and poultry housing accumulate dense populations of Musca domestica (house fly), Stomoxys calcitrans (stable fly), and Alphitobius diaperinus (lesser mealworm or litter beetle). Malathion is deployed in these environments as a residual surface spray, not as an on-animal treatment. The typical formulation format is an emulsifiable concentrate at 50–57% w/w malathion, which is diluted at the point of use to 0.5–1.0% w/v active in water and applied at 4–10 L of finished spray per 100 m² of treated surface. Target surfaces include concrete floors, wooden slats, wall junctions, nest boxes, curtain walls, and manure storage area perimeters. The pyrethroid and organophosphate resistance pressure in Musca domestica across intensive animal agriculture dictates that malathion should be rotated with unrelated mode-of-action insecticides in a structured resistance management program; continuous use of the same organophosphate at the same site for more than three consecutive house fly generations is contraindicated and accelerates resistance allele fixation. A spray application provides a residual film with 2–4 weeks of insecticidal activity on non-porous surfaces; on highly alkaline concrete (pH above 9.0), hydrolysis deactivates the malathion film within 7–10 days, which is a known operational limitation. The manufacturing process for this category mirrors the sheep dip EC route—jacketed stainless steel vessel, aromatic solvent, emulsifier blend, homogenization—but solvent selection shifts toward higher-flash-point aromatic solvents (flash point above 65°C per ASTM D93) for indoor premises use to meet occupational safety thresholds during spray application. The formulation addition ratio for the API is 50–57% w/w in the concentrate; the point-of-use dilution ratio of 1:100 to 1:200 (concentrate-to-water) generates the 0.5–1.0% active spray. Spray equipment for this sector includes hydraulic pump sprayers with operating pressure 20–30 bar (290–435 psi), flat fan nozzles (80° angle, 0.2–0.4 GPM), and wand extension for crack-and-crevice treatment. Premises treatment is regulated under EPA FIFRA Section 3 in the United States (40 CFR 180.111 tolerances), EU Biocidal Products Regulation (EU) No 528/2012 for biocidal product categories where applicable, and national occupational exposure frameworks. VICH GL18 controls residual solvent levels in the finished EC. Terminal product types: 50% EC in 1-L and 5-L packs; 57% EC in 20-L drums for commercial producers; ready-to-use 0.5% spray trigger bottles for small operations; and water-soluble packet formulations at 40% active for pre-measured dilution without direct concentrate handling.

    Swine Lice and Mange Spray Concentrates: Dilution Ratios and Sprayer Calibration

    Haematopinus suis (hog louse) and Sarcoptes scabiei var. suis (sarcoptic mange mite) cause measurable production losses in confined swine: reduced growth rate, feed conversion efficiency decline, and—in severe mange cases—secondary bacterial dermatitis. The target spray formulation for this application is a 0.25–0.5% w/v malathion solution prepared by diluting a 50% EC at 1:100 to 1:200 with water. Mange mites that burrow in the stratum corneum require the active ingredient to be forced into the skin interface; therefore, high-pressure spraying at 14–21 bar (200–300 psi) is specified, delivering 0.5–1.0 L of finished solution per sow and 0.25–0.5 L per grower pig. The nozzle configuration is flat fan (80° angle, 0.2–0.4 GPM), boom height 30–45 cm above the animal's back, and a walking speed of 1.0–1.5 m/s for backpack sprayer operation. Two treatments separated by 7–14 days are mandatory for sarcoptic mange, because the organophosphate exerts no ovicidal activity and the egg-to-larva hatch interval in a skin burrow environment ranges from 3 to 10 days depending on ambient temperature within the pen. Water quality parameters for dilution are operationally decisive: pH should be adjusted to 5.0–6.5 using a citrate or phosphate buffer because alkaline water (pH above 7.5) accelerates malathion hydrolysis and shortens tank-life below 4 hours. Water hardness above 300 mg/L CaCO₃ can destabilize the anionic emulsifier; when hard water is unavoidable, a nonionic surfactant is added at 0.05% v/v to maintain emulsion integrity. The reconstituted spray should be used within 8 hours of mixing; overnight storage in the spray tank without recirculation leads to creaming and uneven active distribution at the nozzle. Compliance anchors: 21 CFR 556.370 for swine meat, liver, and fat residues; 40 CFR 180.111; 29 CFR 1910.1000 Table Z-1 (PEL 15 mg/m³ total dust; for spray application, dermal exposure limits and chemical-resistant gloves are mandated); and 29 CFR 1910.1200 (Hazard Communication) for labeling and safety data sheet requirements. Meat withdrawal periods of 1–7 days (jurisdiction-dependent) require verification against the specific registered label. Terminal product types: 50% EC for spray dilution in 1-L and 5-L packaging; 0.5% ready-to-use spray in 4-L jugs; and 0.25% low-volume misting concentrate in 20-L drums for automated pen sprayers.

    Malathion 0.5% lotions, shampoos, and dips for canine flea (Ctenocephalides felis) and tick (Rhipicephalus sanguineus) control were registered in multiple markets between the 1960s and the early 2000s. Current regulatory status is fragmented: the US FDA and EPA registrations for several companion animal malathion topical products have been withdrawn or discontinued, while in some jurisdictions pharmacy-compounded preparations under veterinary prescription remain available using veterinary-grade malathion API. This regulatory boundary must be documented by any API supplier to avoid downstream misuse. The dosage forms that have valid historical or current registrations include: 0.5% w/v malathion in an aqueous lotion with isopropyl alcohol as a co-solvent; 0.5% otic solution for ear mite (Otodectes cynotis) treatment in cats and dogs; and 0.25–0.5% canine dip wash. The delivery route is exclusively topical because oral or parenteral administration of malathion to companion animals is prohibited by its mammalian acetylcholinesterase inhibition profile; tablets, capsules, and injectable malathion products are not registered in any major veterinary market and no maximum residue limit framework exists for such routes. The pharmaceutical-grade (veterinary-grade) API requirement for this sector is the most stringent of the six application scenarios described: the purified API must demonstrate depletion of toxicologically relevant impurities including isomalathion (a phosphorodithioate isomer linked to delayed neurotoxicity potentiation), malaoxon (the oxon analog with approximately 100-fold higher acetylcholinesterase inhibition than the parent thion), and O,S,S-trimethyl phosphorodithioate (a known potentiation agent for malathion mammalian toxicity). The FAO/WHO JMPS specification for technical-grade malathion controls isomalathion content at or below 0.4% w/w; veterinary-grade material should be specified below this threshold, typically ≤0.2% w/w, with malaoxon capped at ≤0.1% w/w or lower when the finished formulation contains more than 0.5% active ingredient. Residual solvent control under VICH GL18 is mandatory for any alcohol- or ether-containing formulation. Stability per VICH GL11 at 25°C and 60% RH for 24 months must be demonstrated. Sterility is not required for topical lotions, but the API must meet a bioburden specification of ≤100 CFU/g with absence of Staphylococcus aureus and Pseudomonas aeruginosa. Terminal product types in current or recent regulatory use: 0.5% malathion lotion in 60-mL and 120-mL bottles; 0.5% otic solution in 15-mL dropper bottles; and 0.25% dip concentrate in 473-mL bottles for dilution. Operational incompatibility: malathion topical preparations must not be combined with acetylcholinesterase-inhibiting antiparasitics (e.g., other organophosphates or carbamates such as carbaryl) on the same animal within 30 days; combined exposure produces additive cholinergic toxicity. Concurrent use with cholinesterase-inhibiting systemic drugs (e.g., neostigmine, pyridostigmine) is contraindicated without direct veterinary supervision.

    Free Quote

    Competitive Purified Malathion Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please contact us at +8618963613625 or mail to sales10@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8618963613625

    Email: sales10@sinochem-nanjing.com

    Inquiry

    Get Free Quote of Ascent Petrochem Holdings Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    The compound described herein as purified malathion veterinary-grade active pharmaceutical ingredient is diethyl (dimethoxythiophosphorylthio)succinate, CAS 121-75-5, supplied as a clear colourless to pale amber oily liquid. The molecular formula is C10H19O6PS2 and the molecular weight is 330.36 g/mol. It is intended for formulation into licensed veterinary tablets, capsules, powders, granules, premixes, solutions and non-aqueous injectable preparations. The purified grade is released against a minimum assay of 98.0% on an anhydrous basis by gas chromatography with flame ionisation detection, while the technical-grade alternative may be supplied at 95.0% minimum assay. Model suffixes such as “-95” and “-98” are supplier-specific and denote minimum assay value only; they do not replace pharmacopoeial or regulatory compliance. The substance is an organophosphate acetylcholinesterase inhibitor with primary veterinary utility as an ectoparasiticide against mites, lice, ticks, fleas and certain nuisance flies. Because malathion remains liquid at normal warehouse temperatures, dry oral and topical dosage forms require adsorption onto a solid carrier or incorporation into a solvent system before compression, encapsulation or granulation.

    Key intrinsic parameters controlling dosage-form design are water solubility of 145 mg/L at 20 °C, log Kow of 2.36 and density of 1.23 g/cm³ at 20 °C. Refractive index n20/D is approximately 1.4985. The low aqueous solubility explains why unmodified aqueous admixtures exhibit poor active distribution, and the log Kow indicates preferential partitioning into lipophilic vehicles and biological lipids. Bulk storage should maintain a nitrogen headspace and a temperature below 25 °C to limit oxidative by-product formation; repeated exposure to ambient air should be minimised.

    ParameterValueTechnical relevance
    CAS121-75-5Identity and regulatory cross-reference
    Molecular formulaC10H19O6PS2Used in stability and degradation calculations
    Molecular weight330.36 g/molBasis for stoichiometric dose calculations
    Density at 20 °C1.23 g/cm³Metering and liquid-fill calculations
    Water solubility at 20 °C145 mg/LExplains aqueous-formulation constraints
    log Kow2.36Lipid partitioning and carrier selection
    Refractive index n20/D1.4985Incoming identity and purity check
    Minimum assay, purified grade98.0%Release criterion by GC-FID
    Minimum assay, technical grade95.0%Bulk agricultural or unrefined feedstock

    What Limits Direct Incorporation into Aqueous and Lipid-Based Veterinary Vehicles?

    Direct aqueous incorporation is constrained by the 145 mg/L water solubility, so solutions and emulsions normally require a co-solvent, oil phase or surfactant package. In aqueous emulsions, pH is maintained between 4.0 and 6.0; hydrolysis accelerates above pH 7.0, and unbuffered batches drifting to pH 6.5 during storage are vulnerable to active loss. A non-ionic emulsifier combination such as polysorbate 80 and sorbitan monooleate is typically used at 5–10% w/w relative to the oil phase. High-shear mixing with a rotor-stator homogeniser at 3,000–10,000 rpm is used to reduce droplet diameter below 10 μm; production-scale processing should follow the shear step with low-shear anchor agitation to limit droplet coalescence. The pH-dependent hydrolysis behaviour of organothiophosphate esters is well documented, although published data for any specific finished veterinary formulation may be limited.

    For dry oral forms, the liquid API is adsorbed onto colloidal silicon dioxide, precipitated silica, calcium silicate or low-moisture maltodextrin before dry blending. A liquid load of 20–30 wt% is generally manageable; higher loads produce paste lumps and poor content uniformity in V-blenders or bin blenders. In wet granulation, the API-carrier adsorbate is combined with a povidone or hydroxypropyl methylcellulose binder in a high-shear granulator. Typical processing parameters for a 25 L bowl include impeller speed of 150–300 rpm and chopper speed of 1,500 rpm, but scale-up must be confirmed by sieve analysis and content uniformity. Because the active is not freely water-soluble, direct compression is limited to formulations in which the drug has been pre-adsorbed and milled below the required particle-size threshold.

    When a 98.0% Assay Grade Replaces Technical 95% Feedstock in Multi-Dosage-Form Production

    Substitution of technical-grade feedstock with purified material changes analytical release, dry-mix behaviour and operator exposure control. The higher minimum assay reduces the need for overage allowances of 5–10% that may otherwise be included for activity uncertainty. The purified product also presents a lower burden of organosulfur odorants and residual processing solvents, which reduces odour-driven batch rejections and lowers airborne solvent exposure during adsorption and granulation. Tablets manufactured with an appropriately adsorbed purified API are controlled by USP <905> uniformity of dosage units; the standard acceptance value applies, and no additional pharmacopoeial allowance for liquid adsorption is required if the adsorbate is pre-screened through a 500 μm sieve. With technical material, powder adhesion to blender walls and segregation on lactose monohydrate carriers are more pronounced. Pilot-scale uniformity studies are still required before routine production because powder rheology and granule densification are formulation-specific.

    The purified grade differs from unrefined technical malathion in impurity control as well as in odour profile. Isomalathion and malaoxon are controlled at low specified limits because both substances have greater toxicological relevance than the parent compound. Residual solvents are controlled according to ICH Q3C Option 1. Elemental impurities are controlled by ICH Q3D risk assessment and measured using USP <232> and USP <233>. Water content is determined by Karl Fischer titration and is maintained below 0.1% w/w to protect hydrolysis-sensitive formulations. The comparative profile is summarised in the following table.

    PropertyPurified veterinary gradeTechnical grade
    Minimum assay98.0%95.0%
    Isomalathion and malaoxonLow specified limits by current compendial or registered specificationOften higher and not standardised for veterinary drug use
    Residual solventsICH Q3C Option 1May vary with manufacturing route
    Elemental impuritiesICH Q3D risk-assessedNot routinely controlled
    Odour profileLower organosulfur volatile loadStronger characteristic odour
    Water contentBelow 0.1% w/wNot always controlled for solids or bulk liquid

    Stability-Limiting Parameters in Solid, Semi-Solid and Liquid Dosage Forms

    Stability in formulated product is governed by pH, temperature, light, oxygen and trace metals. Aqueous systems are most stable in a weakly acidic range; citrate or phosphate buffers at pH 4.0–5.5 are common. Thermal degradation increases above 40 °C, and peroxide-containing surfactants accelerate malaoxon formation. Butylated hydroxytoluene at 0.01–0.05% w/w or butylated hydroxyanisole is used in oil-based solutions to suppress oxidative degradation. Disodium edetate at 0.01% w/v can reduce trace-metal-catalysed decomposition in aqueous emulsions. For powders and granules, hygroscopic carriers should be pre-dried when ambient relative humidity exceeds 60%; residual moisture above 2.0% w/w in an adsorbed powder can promote hydrolysis during storage. Packaging should be opaque high-density polyethylene with sealed closures. Polyvinyl chloride may sorb lipophilic organophosphate and should be avoided for liquid premix unless compatibility is specifically demonstrated. Storage below 25 °C and protection from light are expected to preserve assay over the retest period, and new formulations require stress studies under ICH Q1A(R2) conditions before commercial distribution.

    For tablet and capsule dosage forms, the API is not direct-compression tolerant; it is adsorbed and then blended with microcrystalline cellulose, lactose monohydrate, croscarmellose sodium and magnesium stearate. Soft gelatin capsules may be filled with a solution of malathion in medium-chain triglycerides, but the fill mass must be evaluated for gelatin seam integrity and water migration. For injection, an aqueous vehicle is unsuitable because of solubility, pH and toxicological constraints. Non-aqueous vehicles based on propylene glycol, glycofurol or a mixture with ethanol are used only where a registered injectable product exists. Terminal steam sterilisation is not recommended because of thermal degradation at autoclave temperatures; membrane filtration through 0.22 μm filters is the more appropriate sterilisation method for non-aqueous solutions. Published data for this specific configuration is limited, and parenteral use in food-producing animals requires residue and withdrawal considerations in the regulatory submission.

    In powders and granules, the purified API is sprayed or adsorbed onto carriers such as kaolin, attapulgite, precipitated silica or calcium carbonate. Premix manufacture for medicated feed requires stepwise dilution: a first active-carrier premix of 1:9 or 1:99 is prepared, followed by geometric blending in a ribbon mixer fitted with spray bars for liquid addition. Particles should pass a 500 μm sieve after final blending, and segregation tendency should be evaluated using ASTM D6940 or an equivalent validated method. Batch-to-batch flow variability is minimised when the liquid load on the carrier remains below 30% w/w. Granulation with a twin-screw extruder having an L/D ratio of 25:1 can generate dense granules, but the barrel temperature should remain below 50 °C to avoid thermal degradation. The purified product is also incompatible with strong alkalies, amines and oxidising agents; these materials should not be combined in the same premix or granulation because they accelerate hydrolysis and oxidative by-product formation.

    Topical solutions and pour-on products are prepared by dissolving the purified API in ethanol, isopropanol, propylene glycol or medium-chain triglycerides. For dips and sprays, an emulsifiable concentrate is prepared with a high-boiling solvent and non-ionic emulsifier; the diluted emulsion should be used within 24 h because pH-dependent hydrolysis can occur in hard water. Water used for dilution should be free of excessive hardness or stabilised with a chelator. The product differs from technical-grade malathion principally in lower isomalathion and malaoxon content, lower residual solvent burden and a tighter elemental impurity profile. It also differs from other organophosphate veterinary actives in species sensitivity, withdrawal periods and prescribing restrictions; cholinesterase monitoring remains necessary when any organophosphate is used concurrently with other acetylcholinesterase inhibitors.

    Top